TY - JOUR
T1 - Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons
AU - Wickersham, Ian R.
AU - Sullivan, Heather A.
AU - Seung, Hyunjune Sebastian
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2010/3
Y1 - 2010/3
N2 - Recombinant rabies viruses rendered replication-deficient by the deletion of their envelope glycoprotein gene are useful tools for neuroscientists, permitting (1) extraordinarily high transgene expression levels within neurons, (2) retrograde infection of projection neurons through their axon terminals, (3) targeted infection of genetically specified neurons and (4) monosynaptic tracing of neuronal inputs. Here we present a detailed protocol for the production of high-titer and high-purity viral stocks, from initial generation of infectious virus from cDNA through amplification on complementing cell lines, pseudotyping if desired, purification by ultracentrifugation and titering. The procedure requires 3-4 weeks to complete.
AB - Recombinant rabies viruses rendered replication-deficient by the deletion of their envelope glycoprotein gene are useful tools for neuroscientists, permitting (1) extraordinarily high transgene expression levels within neurons, (2) retrograde infection of projection neurons through their axon terminals, (3) targeted infection of genetically specified neurons and (4) monosynaptic tracing of neuronal inputs. Here we present a detailed protocol for the production of high-titer and high-purity viral stocks, from initial generation of infectious virus from cDNA through amplification on complementing cell lines, pseudotyping if desired, purification by ultracentrifugation and titering. The procedure requires 3-4 weeks to complete.
UR - http://www.scopus.com/inward/record.url?scp=77749320537&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77749320537&partnerID=8YFLogxK
U2 - 10.1038/nprot.2009.248
DO - 10.1038/nprot.2009.248
M3 - Article
C2 - 20203674
AN - SCOPUS:77749320537
SN - 1754-2189
VL - 5
SP - 595
EP - 606
JO - Nature Protocols
JF - Nature Protocols
IS - 3
ER -